Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers.

Meibody F, Jamme M, Tsatsaris V, Provot F, Lambert J, Frémeaux-Bacchi V, Ducloy-Bouthors AS, Jourdain M, Delmas Y, Perez P, Darmian J, Wynckel A, Rebibou JM, Coppo P, Rafat C, Rondeau E, Frimat L, Hertig A.

Nephrol Dial Transplant. 2019 Feb 25. pii: gfz025. doi: 10.1093/ndt/gfz025. [Epub ahead of print]

PMID:
30805631
2.

Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.

Monet-Didailler C, Godron-Dubrasquet A, Madden I, Delmas Y, Llanas B, Harambat J.

Pediatr Nephrol. 2019 Apr;34(4):657-662. doi: 10.1007/s00467-018-4131-z. Epub 2018 Oct 27.

PMID:
30368614
3.

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.

Chauvet S, Roumenina LT, Aucouturier P, Marinozzi MC, Dragon-Durey MA, Karras A, Delmas Y, Le Quintrec M, Guerrot D, Jourde-Chiche N, Ribes D, Ronco P, Bridoux F, Fremeaux-Bacchi V.

Front Immunol. 2018 Oct 2;9:2260. doi: 10.3389/fimmu.2018.02260. eCollection 2018.

4.

ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman Syndrome.

Joly BS, Boisseau P, Roose E, Stepanian A, Biebuyck N, Hogan J, Provot F, Delmas Y, Garrec C, Vanhoorelbeke K, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Thromb Haemost. 2018 Nov;118(11):1902-1917. doi: 10.1055/s-0038-1673686. Epub 2018 Oct 12.

PMID:
30312976
5.

Immune-Thrombotic Thrombocytopenic Purpura is a Rare Cause of Ischemic Stroke in Young Adults: Case Reports and Literature Review.

Tomich C, Debruxelles S, Delmas Y, Sagnier S, Poli M, Olindo S, Renou P, Rouanet F, Sibon I.

J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3163-3171. doi: 10.1016/j.jstrokecerebrovasdis.2018.07.017. Epub 2018 Sep 12. Review.

PMID:
30217637
6.

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.

Jestin M, Benhamou Y, Schelpe AS, Roose E, Provôt F, Galicier L, Hié M, Presne C, Poullin P, Wynckel A, Saheb S, Deligny C, Servais A, Girault S, Delmas Y, Kanouni T, Lautrette A, Chauveau D, Mousson C, Perez P, Halimi JM, Charvet-Rumpler A, Hamidou M, Cathébras P, Vanhoorelbeke K, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Center.

Blood. 2018 Nov 15;132(20):2143-2153. doi: 10.1182/blood-2018-04-840090. Epub 2018 Sep 10.

PMID:
30201758
7.

Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters.

Sacher F, Jesel L, Borni-Duval C, De Precigout V, Lavainne F, Bourdenx JP, Haddj-Elmrabet A, Seigneuric B, Keller A, Ott J, Savel H, Delmas Y, Bazin-Kara D, Klotz N, Ploux S, Buffler S, Ritter P, Rondeau V, Bordachar P, Martin C, Deplagne A, Reuter S, Haissaguerre M, Gourraud JB, Vigneau C, Mabo P, Maury P, Hannedouche T, Benard A, Combe C.

JACC Clin Electrophysiol. 2018 Mar;4(3):397-408. doi: 10.1016/j.jacep.2017.08.002. Epub 2017 Sep 27.

8.

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.

Le Quintrec M, Lapeyraque AL, Lionet A, Sellier-Leclerc AL, Delmas Y, Baudouin V, Daugas E, Decramer S, Tricot L, Cailliez M, Dubot P, Servais A, Mourey-Epron C, Pourcine F, Loirat C, Frémeaux-Bacchi V, Fakhouri F.

Am J Kidney Dis. 2018 Jul;72(1):84-92. doi: 10.1053/j.ajkd.2017.11.019. Epub 2018 Feb 9.

PMID:
29429752
9.

Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome.

Dorval G, Gribouval O, Martinez-Barquero V, Machuca E, Tête MJ, Baudouin V, Benoit S, Chabchoub I, Champion G, Chauveau D, Chehade H, Chouchane C, Cloarec S, Cochat P, Dahan K, Dantal J, Delmas Y, Deschênes G, Dolhem P, Durand D, Ekinci Z, El Karoui K, Fischbach M, Grunfeld JP, Guigonis V, Hachicha M, Hogan J, Hourmant M, Hummel A, Kamar N, Krummel T, Lacombe D, Llanas B, Mesnard L, Mohsin N, Niaudet P, Nivet H, Parvex P, Pietrement C, de Pontual L, Noble CP, Ribes D, Ronco P, Rondeau E, Sallee M, Tsimaratos M, Ulinski T, Salomon R, Antignac C, Boyer O.

Pediatr Nephrol. 2018 Mar;33(3):473-483. doi: 10.1007/s00467-017-3819-9. Epub 2017 Oct 23.

PMID:
29058154
10.

Hemolytic Uremic Syndrome in Pregnancy and Postpartum.

Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EKS, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C, Frémeaux-Bacchi V, Fakhouri F.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1237-1247. doi: 10.2215/CJN.00280117. Epub 2017 Jun 8.

11.

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome.

Jamme M, Raimbourg Q, Chauveau D, Seguin A, Presne C, Perez P, Gobert P, Wynckel A, Provôt F, Delmas Y, Mousson C, Servais A, Vrigneaud L, Veyradier A, Rondeau E, Coppo P; French Thrombotic Microangiopathies Reference Centre.

PLoS One. 2017 May 18;12(5):e0177894. doi: 10.1371/journal.pone.0177894. eCollection 2017.

12.

Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.

Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P, Grange S, Halimi JM, Lautrette A, Delmas Y, Presne C, Hamidou M, Girault S, Pène F, Perez P, Kanouni T, Seguin A, Mousson C, Chauveau D, Ojeda-Uribe M, Barbay V, Veyradier A, Coppo P, Benhamou Y.

Am J Hematol. 2017 Apr;92(4):381-387. doi: 10.1002/ajh.24665. Epub 2017 Feb 21.

13.

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

Chauvet S, Frémeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, Choukroun G, Delmas Y, Guerrot D, François A, Le Quintrec M, Javaugue V, Ribes D, Vrigneaud L, Arnulf B, Goujon JM, Ronco P, Touchard G, Bridoux F.

Blood. 2017 Mar 16;129(11):1437-1447. doi: 10.1182/blood-2016-08-737163. Epub 2017 Jan 9.

14.

High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy.

Imasawa T, Obre E, Bellance N, Lavie J, Imasawa T, Rigothier C, Delmas Y, Combe C, Lacombe D, Benard G, Claverol S, Bonneu M, Rossignol R.

FASEB J. 2017 Jan;31(1):294-307. doi: 10.1096/fj.201600293R. Epub 2016 Oct 17.

15.

Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.

Fakhouri F, Fila M, Provôt F, Delmas Y, Barbet C, Châtelet V, Rafat C, Cailliez M, Hogan J, Servais A, Karras A, Makdassi R, Louillet F, Coindre JP, Rondeau E, Loirat C, Frémeaux-Bacchi V.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):50-59. doi: 10.2215/CJN.06440616. Epub 2016 Oct 31.

16.

Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab.

Servais A, Devillard N, Frémeaux-Bacchi V, Hummel A, Salomon L, Contin-Bordes C, Gomer H, Legendre C, Delmas Y.

Nephrol Dial Transplant. 2016 Dec;31(12):2122-2130. Epub 2016 Sep 1.

PMID:
27587606
17.

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.

Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.

PMID:
27132698
18.

Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment.

Walle JV, Delmas Y, Ardissino G, Wang J, Kincaid JF, Haller H.

J Nephrol. 2017 Feb;30(1):127-134. doi: 10.1007/s40620-016-0288-3. Epub 2016 Mar 19.

19.

Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.

Soucemarianadin M, Benhamou Y, Delmas Y, Pichereau C, Maury E, Pène F, Halimi JM, Presne C, Thouret JM, Veyradier A, Coppo P.

Eur J Haematol. 2016 Aug;97(2):183-91. doi: 10.1111/ejh.12706. Epub 2016 Jan 6.

PMID:
26608617
20.

Isonatric Dialysis Biofeedback in Hemodiafiltration with Online Regeneration of Ultrafiltrate in Hypertensive Hemodialysis Patients: A Randomized Controlled Study.

Chevalier L, Tielemans C, Debelle F, Vandervelde D, Fumeron C, Mandart L, Stolear JC, Simon I, Delmas Y, Testa A, Mat O, Tezenas du Montcel S, Mercadal L.

Blood Purif. 2016;41(1-3):87-93. doi: 10.1159/000441967. Epub 2015 Nov 19.

PMID:
26580275
21.

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura.

Roriz M, Landais M, Desprez J, Barbet C, Azoulay E, Galicier L, Wynckel A, Baudel JL, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Chauveau D, Veyradier A, Halimi JM, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center.

Medicine (Baltimore). 2015 Oct;94(42):e1598. doi: 10.1097/MD.0000000000001598.

22.

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.

Delmas Y, Helou S, Chabanier P, Ryman A, Pelluard F, Carles D, Boisseau P, Veyradier A, Horovitz J, Coppo P, Combe C.

BMC Pregnancy Childbirth. 2015 Jun 17;15:137. doi: 10.1186/s12884-015-0557-5.

23.

Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.

Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C.

Am J Kidney Dis. 2015 Aug;66(2):331-6. doi: 10.1053/j.ajkd.2015.03.039. Epub 2015 May 23.

PMID:
26015278
24.

Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet count.

Riviere E, Saint-Léger M, James C, Delmas Y, Clouzeau B, Bui N, Vital A, Coppo P, Gruson D, Boyer A.

Transfusion. 2015 Jul;55(7):1798-802. doi: 10.1111/trf.13041. Epub 2015 Feb 20.

PMID:
25702952
25.

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.

Licht C, Greenbaum LA, Muus P, Babu S, Bedrosian CL, Cohen DJ, Delmas Y, Douglas K, Furman RR, Gaber OA, Goodship T, Herthelius M, Hourmant M, Legendre CM, Remuzzi G, Sheerin N, Trivelli A, Loirat C.

Kidney Int. 2015 May;87(5):1061-73. doi: 10.1038/ki.2014.423. Epub 2015 Feb 4.

26.

Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.

Benhamou Y, Boelle PY, Baudin B, Ederhy S, Gras J, Galicier L, Azoulay E, Provôt F, Maury E, Pène F, Mira JP, Wynckel A, Presne C, Poullin P, Halimi JM, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Cohen A, Veyradier A, Coppo P; Reference Center for Thrombotic Microangiopathies.

J Thromb Haemost. 2015 Feb;13(2):293-302. doi: 10.1111/jth.12790. Epub 2014 Dec 18.

27.

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Hélou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C.

Nephrol Dial Transplant. 2014 Mar;29(3):565-72. doi: 10.1093/ndt/gft470. Epub 2013 Nov 28.

28.

Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency.

Cornec-Le Gall E, Delmas Y, De Parscau L, Doucet L, Ogier H, Benoist JF, Fremeaux-Bacchi V, Le Meur Y.

Am J Kidney Dis. 2014 Jan;63(1):119-23. doi: 10.1053/j.ajkd.2013.08.031. Epub 2013 Nov 6.

PMID:
24210589
29.

Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.

Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.

Am J Kidney Dis. 2014 Jan;63(1):40-8. doi: 10.1053/j.ajkd.2013.07.011. Epub 2013 Sep 8.

PMID:
24021908
30.

Erratum: Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice.

Delmas Y, Bordes C, Loirat C, Frémeaux-Bacchi V, Combe C.

Clin Kidney J. 2013 Aug;6(4):454. doi: 10.1093/ckj/sft098.

31.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.

N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.

32.

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.

Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center.

Transfusion. 2014 Feb;54(2):389-97. doi: 10.1111/trf.12263. Epub 2013 May 27.

PMID:
23711330
33.

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice.

Delmas Y, Bordes C, Loirat C, Frémeaux-Bacchi V, Combe C.

Clin Kidney J. 2013 Apr;6(2):243-4. doi: 10.1093/ckj/sfs185. No abstract available. Erratum in: Clin Kidney J. 2013 Aug;6(4):454.

34.

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura.

Moatti-Cohen M, Garrec C, Wolf M, Boisseau P, Galicier L, Azoulay E, Stepanian A, Delmas Y, Rondeau E, Bezieau S, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Blood. 2012 Jun 14;119(24):5888-97. doi: 10.1182/blood-2012-02-408914. Epub 2012 Apr 30.

35.

Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.

King LA, Nogareda F, Weill FX, Mariani-Kurkdjian P, Loukiadis E, Gault G, Jourdan-DaSilva N, Bingen E, Macé M, Thevenot D, Ong N, Castor C, Noël H, Van Cauteren D, Charron M, Vaillant V, Aldabe B, Goulet V, Delmas G, Couturier E, Le Strat Y, Combe C, Delmas Y, Terrier F, Vendrely B, Rolland P, de Valk H.

Clin Infect Dis. 2012 Jun;54(11):1588-94. doi: 10.1093/cid/cis255. Epub 2012 Mar 28.

PMID:
22460976
36.

Immunoadsorption in patients with haemolytic uraemic syndrome.

Combe C, Bui HN, de Précigout V, Hilbert G, Delmas Y.

Lancet. 2012 Feb 11;379(9815):517-8; author reply 518-9. doi: 10.1016/S0140-6736(12)60228-1. No abstract available.

PMID:
22325656
37.

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.

Stankovic Stojanovic K, Delmas Y, Torres PU, Peltier J, Pelle G, Jéru I, Colombat M, Grateau G.

Nephrol Dial Transplant. 2012 May;27(5):1898-901. doi: 10.1093/ndt/gfr528. Epub 2011 Sep 19.

PMID:
21931121
38.

Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, south-western France, June 2011.

Aldabe B, Delmas Y, Gault G, Vendrely B, Llanas B, Charron M, Castor C, Ong N, Weill F, Mariani-Kurkdjian P, Terrier F, Desjardin M, Simoes J, Le Bihan B, Combe C, Rolland P.

Euro Surveill. 2011 Aug 4;16(31). pii: 19934.

39.

Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats.

Derieppe M, Delmas Y, Gennisson JL, Deminière C, Placier S, Tanter M, Combe C, Grenier N.

Eur Radiol. 2012 Jan;22(1):243-50. doi: 10.1007/s00330-011-2229-9. Epub 2011 Aug 16.

PMID:
21845464
40.

Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli O104:H4, south-west France, June 2011.

Gault G, Weill FX, Mariani-Kurkdjian P, Jourdan-da Silva N, King L, Aldabe B, Charron M, Ong N, Castor C, Mace M, Bingen E, Noel H, Vaillant V, Bone A, Vendrely B, Delmas Y, Combe C, Bercion R, d'Andigne E, Desjardin M, de Valk H, Rolland P.

Euro Surveill. 2011 Jun 30;16(26). pii: 19905. No abstract available.

41.

Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome.

Pelras S, Delmas Y, Lamireau D, Villega F, Nolent P, Ryman A, Llanas B, Brissaud O, Harambat J.

Pediatr Nephrol. 2011 Apr;26(4):631-5. doi: 10.1007/s00467-010-1721-9. Epub 2010 Dec 15.

PMID:
21161282
42.

Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.

Harambat J, Lamireau D, Delmas Y, Ryman A, Llanas B, Brissaud O.

Pediatr Crit Care Med. 2011 Mar;12(2):e90-3. doi: 10.1097/PCC.0b013e3181e89f8f.

PMID:
20625343
43.

[Chronic renal complications induced by lithium].

Le Roy V, Delmas Y, Verdoux H.

Encephale. 2009 Dec;35(6):605-10. doi: 10.1016/j.encep.2008.12.007. Review. French.

PMID:
20004292
44.

Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.

Dussol B, Morange S, Burtey S, Indreies M, Cassuto E, Mourad G, Villar E, Pouteil-Noble C, Karaaslan H, Sichez H, Lasseur C, Delmas Y, Nogier MB, Fathallah M, Loundou A, Mayor V, Berland Y.

Am J Kidney Dis. 2008 Oct;52(4):699-705. doi: 10.1053/j.ajkd.2008.04.013. Epub 2008 Jun 30.

PMID:
18585835
45.

USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans.

Hauger O, Grenier N, Deminère C, Lasseur C, Delmas Y, Merville P, Combe C.

Eur Radiol. 2007 Nov;17(11):2898-907. Epub 2007 May 22.

PMID:
17929025
46.

[Biology of renal functions and renal insufficiency].

Cristol JP; Biologie des Fonctions Rénales et de l'Insuffisance Rénale; Société Française de Biologie Clinique, Seronie-Vivien S, Sternberg M, Cavalier E, Blanchecotte F, Hanser AM, Pieroni L, Galteau MM, Monge M, Boutten A, Desch G, Ait Djafer Z, Carlier MC, Barguil Y, Terrier N, Guerber F, Souberbielle JC, Delmas Y, Delanaye P, Panescu V, Rossert J, Fouqueray B, Houillier P, Froissart M, Lefebvre HP, Canaud B, Halimi JM.

Ann Biol Clin (Paris). 2006 Nov-Dec;64(6):608-11. French. No abstract available.

47.

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.

Terrier B, Delmas Y, Hummel A, Presne C, Glowacki F, Knebelmann B, Combe C, Lesavre P, Maillard N, Noël LH, Patey-Mariaud de Serre N, Nusbaum S, Radford I, Buzyn A, Fakhouri F.

Nephrol Dial Transplant. 2007 May;22(5):1369-76. Epub 2007 Jan 25.

PMID:
17255123
48.

Verapamil and mild hyperkalemia in hemodialysis patients: a potentially hazardous association.

Letavernier E, Couzi L, Delmas Y, Moreau K, Murcott O, de Précigout V.

Hemodial Int. 2006 Apr;10(2):170-2.

PMID:
16623670
49.

MR imaging of nephropathies.

Grenier N, Hauger O, Delmas Y, Combe C.

Abdom Imaging. 2006 Mar-Apr;31(2):213-23. Review.

PMID:
16447088
50.

MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy.

Hauger O, Frost EE, van Heeswijk R, Deminière C, Xue R, Delmas Y, Combe C, Moonen CT, Grenier N, Bulte JW.

Radiology. 2006 Jan;238(1):200-10.

PMID:
16373768

Supplemental Content

Loading ...
Support Center